Literature DB >> 8118795

Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.

J Vachtenheim1, I Horáková, H Novotná.   

Abstract

The methylation of MspI/HpaII sites flanking a variable tandem repeat in the 3' region of the c-Ha-ras protooncogene was analyzed in 74 DNA samples of non-small cell lung carcinomas and control lung tissues. Of 39 informative samples, 7 allelic deletions (18%) were found at the c-Ha-ras locus and of these, five (71%) showed hypomethylation of the nondeleted allele. Heterozygous DNA samples without allele loss revealed hypomethylation in 37% (12 of 32). Among 35 homozygotes, 9 showed hypomethylation (26%). We also analyzed c-Ha-ras mutations at codons 12, 13, and 61 by polymerase chain reaction and designed restriction fragment length polymorphism and found no mutation. Thus, c-Ha-ras mutations are not associated with the development of the detected abnormalities. We conclude that hypomethylation at specific sites in the 3' region is associated with loss of heterozygosity for the c-Ha-ras gene in non-small cell lung cancer. The finding that, in informative samples, hypomethylation occurs 2-3 times more frequently than allelic loss suggests that it might be a change contributing or predisposing to a genetic instability that can ultimately lead to c-Ha-ras allelic deletions found in tumor DNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118795

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Methylation matters.

Authors:  J F Costello; C Plass
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

2.  Ha-ras rare alleles in breast cancer susceptibility.

Authors:  K Conway; S Edmiston; D B Fried; B S Hulka; P A Garrett; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

3.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Yoshimasa Saito; Yae Kanai; Michiie Sakamoto; Hidetsugu Saito; Hiromasa Ishii; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

4.  Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.

Authors:  Tsuyoshi Etoh; Yae Kanai; Saori Ushijima; Tohru Nakagawa; Yukihiro Nakanishi; Mitsuru Sasako; Seigo Kitano; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

5.  Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis.

Authors:  Y Kanai; S Ushijima; H Tsuda; M Sakamoto; T Sugimura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1996-12

Review 6.  DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors.

Authors:  Phuc H Hoang; Maria Teresa Landi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

7.  Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck.

Authors:  H Kiaris; D A Spandidos; A S Jones; E D Vaughan; J K Field
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

8.  Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression.

Authors:  S Scarpino; A Di Napoli; M Rapazzotti-Onelli; E Pilozzi; L Ruco
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.